Biotechnology Daily
more-
FDA clears ivWatch’s IV safety monitoring sensor patch
The FDA cleared a miniaturized and disposable sensor patch designed to detect early complications from…
Philips taps BioIntelliSense’s symptom-tracking sticker for COVID-19, other chronic diseases
Amid surge, hospitals hesitate to cancel nonemergency surgeries
Genentech Provides Update on Phase III Study of Tecentriq in Women With Advanced-stage Ovarian Cancer
Big Pharma joins forces on $1B fund to shore up struggling antibiotics makers
Market Watch
more-
Investors face ‘a scary, out-of-whack’ scenario — just look at this chart
‘Just as these stocks pulled up the entire market, they can pull down the entire…
Bio Business News
more
Biopharma Giants Back Launch of AMR Fund with $1 Billion
COVID-19 swept across the globe in a matter of months…
Amgen Announces Additional Investment In BeiGene
THOUSAND OAKS, Calif., — Amgen (NASDAQ:AMGN) today announced an additional investment of…
Harbour BioMed nabs meaty C round as cancer, COVID-19 work draws investors
Just a few months after a series B-plus worth $75…
World News
more
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
FDA clears ivWatch’s IV safety monitoring sensor patch
Philips taps BioIntelliSense’s symptom-tracking sticker for COVID-19, other chronic diseases
Amid surge, hospitals hesitate to cancel nonemergency surgeries
Genentech Provides Update on Phase III Study of Tecentriq in Women With Advanced-stage Ovarian Cancer
Biopharma Giants Back Launch of AMR Fund with $1 Billion
Amgen Announces Additional Investment In BeiGene
Harbour BioMed nabs meaty C round as cancer, COVID-19 work draws investors
Oragenics cans lead program, a treatment for chemo, radiation side effects
Investors face ‘a scary, out-of-whack’ scenario — just look at this chart
Why gold has become a ‘weapon of choice’ for investors